Loading…
Loading…
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for NCTY and 80,000+ other tickers.
See exactly how NCTY's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for NCTY and 80,000+ other tickers.
The9 Limited, an internet enterprise established in 1999 and based in Shanghai, People's Republic of China, conducts its operations through its various subsidiaries. The company's core activities encompass digital currency mining and the oversight of NFTSTAR, its dedicated non-fungible token (NFT) trading and community platform. NFTSTAR facilitates user engagement by enabling the purchase, exchange, and interaction with various digital assets. Initially founded as GameNow.net Limited, the firm officially rebranded as The9 Limited in February 2004.
The9 NASDAQ: NCTY reported second-quarter net income of $32 million, up more than 39% from the prior quarter, as the company advanced its repositioning around The9bit, an AI-powered game creation platform supported by a token-based ecosystem.
Increase driven by the fair-value recognition of 9BIT tokens received under the Company's cooperation agreement with the 9BIT Foundation as the9bit continued to expand AI capabilities, community engagement and commercial partnerships SHANGHAI, Aug. 24, 2026 /PRNewswire/ -- The9 Limited (Nasdaq: NCTY) ("The9" or the "Company"), a global, diversified high-tech company, today reported its unaudited financial results for the three months ended June 30, 2026. Second Quarter 2026 Highlights Strong sequential growth: Net income for the quarter was US$32 million, an increase of more than 39% from the previous quarter.
The9's Investee Nanyang Biologics (NYB) Advancing toward Nasdaq Listing after RFAI Cleared Vote at Shareholders Extraordinary General Meeting
Milestone Marks Further Progress in The9's Strategic Investment in AI-Driven Drug Discovery; The9 Expects to Hold Approximately 15% to 16% of the Combined, Nasdaq-Listed Company SHANGHAI, Aug. 21, 2026 /PRNewswire/ -- The9 Limited (Nasdaq: NCTY) ("The9" or the "Company"), a global, diversified high-tech company, today announced that Nanyang Biologics Pte. Ltd. ("NYB"), a Singapore-based, AI-driven drug discovery company in which The9 holds a strategic equity stake, has taken a significant step toward its planned Nasdaq listing.
SHANGHAI, Aug. 17, 2026 /PRNewswire/ -- The9 Limited (Nasdaq: NCTY) ("The9" or the "Company"), a global, diversified high-tech company, today announced that it will report its unaudited consolidated results for the second quarter ended June 30, 2026, before the U.S. market opens on Monday, August 24, 2026. The Company will host a conference call on Monday, August 24, 2026 at 8:30 PM Hong Kong Time (8:30 AM U.S. Eastern Time) to discuss the results.